Unlock instant, AI-driven research and patent intelligence for your innovation.

Autophagy inducing compound and use thereof

A compound and composition technology, applied in medical preparations containing active ingredients, organic chemistry, drug combination, etc.

Inactive Publication Date: 2013-12-18
HONG KONG BAPTIST UNIV
View PDF6 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Nevertheless, there are no reports or findings concerning the induction of autophagy by such compounds (oxindole alkaloids) in the prior art

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Autophagy inducing compound and use thereof
  • Autophagy inducing compound and use thereof
  • Autophagy inducing compound and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0071] In the following examples, the following materials were used; commercial sources of the various materials are provided. Details of the various experimental protocols are also given below:

[0072] Reagents and antibodies. Isorhynchophylline (APC-164) was purchased from Aktin Chemicals. 3-MA (M9281) and chloroquine (C6628) were purchased from Sigma-Aldrich. Rapamycin (R5000) was purchased from LC Laboratories. Lysosomal red fluorescent probe DND-99 (L-7528), goat anti-mouse (626520) and goat anti-rabbit (G21234) secondary antibodies were purchased from Invitrogen. Anti-β-actin (sc-47778), anti-GFP (sc-8334) and anti-tyrosine hydroxylase (sc-14007) antibodies were purchased from Santa Cruz Biotechnology. Anti-LC3 (2775), anti-phospho-mTOR (5536), anti-phospho-p70S6K (9234), anti-(3738) antibodies were purchased from Cell Signaling Technology. Anti-α-syn antibody (610786) was purchased from BD Transduction Laboratories. Instant Drosophila food (173212) was purchased f...

Embodiment I

[0082] Example 1: IsoRhy induces autophagy in neuronal cell lines

[0083] It has been shown that the induction of autophagy in neuronal cells is much more difficult than in non-neuronal cells. To confirm IsoRhy (whose chemical structure is shown in Figure 1A Induction activity of neuronal autophagy in mouse neuroblastoma N2a, rat pheochromocytoma PC12 and human neuroblastoma SH-SY5Y were treated with different concentrations of IsoRhy for 24 hours, and the cell lysates were subjected to Western blot analysis of expression of LC3-II, which is an autophagy-specific marker. showed that IsoRhy increased LC3-II levels in N2a, PC12 and SH-SY5Y cells in a dose-dependent manner, while LC3-I levels were not affected ( Figure 1B -D).

[0084] In addition, a neuroblastoma cell line N2a that constantly expresses GFP-LC3 (a standard autophagy marker protein) was established. The formation of GFP-LC3 puncta after IsoRhy treatment was observed under a confocal microscope. Data are pre...

Embodiment II

[0088] Example II: IsoRhy Induces Autophagy in Primary Mouse Cortical Neurons

[0089] To further confirm the pro-autophagic effect of IsoRhy on primary neurons, mouse primary cortical neurons isolated from E17 embryonic ICR mice were used in this study. Primary neurons were treated with different concentrations of IsoRhy for 24 hours, and the expression of autophagy marker GFP-LC3 was examined by Western blot analysis. Neurons were fixed in 4% paraformaldehyde and analyzed under a confocal microscope. The number of GFP-LC3 puncta in each GFP positive neuron was counted and at least 20 neurons in each group were counted. Data are expressed as mean ± SEM from one representative experiment out of three independent experiments (***p<0.001, Student's t-test).

[0090] Similarly, a dose-dependent increase in LC3-II induced by IsoRhy was observed in primary mouse cortical neurons ( Figure 3A ). In neurons transfected with the GFP-LC3 construct, IsoRhy induced the massive formatio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is a composition comprising compounds of formulae (I-V) or the salts thereof and the pharmaceutically-acceptable carrier, which is used to treat autophagy-associated diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, etc. Additionally, a method of treating these diseases, as well as the use of said compounds in preparing composition are also disclosed.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to U.S. Provisional Application No. 61 / 466,479, filed March 23, 2011, and U.S. Nonprovisional Application No. 13 / 420,628, filed March 15, 2012, the disclosures of which are incorporated by reference incorporated in this article. technical field [0003] The present invention relates to compositions comprising compounds that induce autophagy. In particular, the present invention relates to compositions comprising autophagy-inducing compounds for degrading abnormal protein deposits in the nervous system by inducing autophagy, and related methods of treatment, such as the treatment of abnormal protein deposits associated with abnormal protein aggregation and / or deposition. neurodegenerative diseases and cancer. Background technique [0004] Macroautophagy, referred to in this paper as autophagy, is a highly conserved physiological process for cellular degradation and reuse of cytoplasmic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/435C07D471/20C07D491/22
CPCA61K31/436A61K31/437A61K45/06A61P21/00A61P25/00A61P25/16A61P25/20A61P25/28A61P31/00A61P35/00A61P43/00C07D471/20A61K2300/00
Inventor 李敏路嘉宏S·S·K·都莱拉詹刘亮锋宋聚先
Owner HONG KONG BAPTIST UNIV